Biomarkers: Discovery and Validation
Course, Master's level, 3MG328
Expand the information below to show details on how to apply and entry requirements.
Spring 2027 Spring 2027, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 3 May 2027–6 June 2027
- Language of instruction
- English
- Entry requirements
-
180 credits in biology, bio-/medicine, biotechnology, pharmaceutical biosciences, medical science or equivalent education giving relevant knowledge in cell biology, genetics biochemistry and molecular biology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits in science and engineering (maximum 240 credits)
- Fees
- Du som inte är medborgare i ett EU-/EES-land eller Schweiz måste i regel betala anmälnings- och studieavgift.
- First tuition fee instalment: SEK 20,625
- Total tuition fee: SEK 20,625
- Application deadline
- 15 October 2026
- Application code
- UU-92005
Admitted or on the waiting list?
Spring 2027 Spring 2027, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 3 May 2027–6 June 2027
- Language of instruction
- English
- Entry requirements
-
180 credits in biology, bio-/medicine, biotechnology, pharmaceutical biosciences, medical science or equivalent education giving relevant knowledge in cell biology, genetics biochemistry and molecular biology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
About the course
The course provides an insight into the current knowledge, future potential use and development of biomarkers as both prognostic and diagnostic tools in health care. Different types of biomarkers will be discussed as well as the methods for the discovery and validation of protein biomarkers in serum. Biomarkers for different diseases will be treated, such as biomarkers for cancers, and neurological and cardiovascular diseases. Biomarkers in disease epidemiology and pathology will be covered. Biobanking and ethical considerations will be discussed and current clinical methods and diagnostics will be illustrated. Current opinions and research findings of molecular biomarkers, as well as the development of novel methods and technologies, will be discussed. The Human Protein Atlas will be described and used in practical exercises, illustrating the discovery of biomarkers for different cancers and other diseases.
Reading list
No reading list found.